Evidence map›Paper›PMID 26193080›Full record

ArticleNature immunology2015

Antigen-specific NK cell memory in rhesus macaques.

R Keith Reeves, Haiying Li, Stephanie Jost, Eryn Blass, Hualin Li, Jamie L Schafer, Valerie Varner, Cordelia Manickam, Leila Eslamizar, Marcus Altfeld and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 190 papers.

0numbers the graph read from it
0cells of the map it votes in
190citing papers in PubMed
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

190 citing papers in PubMed, 279 citations in OpenAlex.

  1. NK Cell Activity and CD57Frontiers in immunology · 2020
    Trial
  2. Trial
  3. Trial
  4. The theory of the inflammatory ecosystem.Science China. Life sciences · 2026
    Review
  5. Article
  6. Immune Responses to Influenza Infection in Children.Open forum infectious diseases · 2026
    Article
  7. Review
  8. Article
  9. CXCR6Frontiers in immunology · 2026
    Article
  10. Review
  11. Challenges and opportunities of human iPSC-derived NK as "Off-the-shelf" cellular therapies.Journal of experimental & clinical cancer research : CR · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

130 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

R Keith Reeves1] Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. [2] Division of Immunology, New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts, USA.
Haiying Li1] Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. [2] Division of Immunology, New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts, USA.
Stephanie JostRagon Institute of Massachusetts General Hospital, MIT, and Harvard, Cambridge, Massachusetts, USA.
Eryn BlassCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Hualin LiCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Jamie L SchaferCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Valerie VarnerCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Cordelia ManickamCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Leila EslamizarCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Marcus Altfeld1] Ragon Institute of Massachusetts General Hospital, MIT, and Harvard, Cambridge, Massachusetts, USA. [2] Heinrich-Pette-Institut, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Ulrich H von Andrian1] Ragon Institute of Massachusetts General Hospital, MIT, and Harvard, Cambridge, Massachusetts, USA. [2] Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Dan H Barouch1] Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. [2] Ragon Institute of Massachusetts General Hospital, MIT, and Harvard, Cambridge, Massachusetts, USA.
Beth Israel Deaconess Medical Center · USRagon Institute of MGH, MIT and Harvard · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Preclinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 VaccineU19AI078526 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI DOLIN, RAPHAEL · 2008 to 2012
$44.0M
VirologyU19AI095985 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BAROUCH, DAN H. · 2011 to 2015
$35.9M
Preclinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 VaccinesU19AI096040 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SEAMAN, MICHAEL SCOTT · 2012 to 2016
$18.0M
P3: Chemokine-Mediated T Cell Trafficking in HIV Transmission and Immune ResponseP01AI112521 · NIAID · HARVARD MEDICAL SCHOOL · PI SHARPE, ARLENE H. · 2014 to 2018
$9.8M
T Cell Activation in Lymph NodesR01AI069259 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI VON ANDRIAN, ULRICH H · 2006 to 2015
$4.5M
NK cell mediated immune pressure in HIV-1 infectionR01AI067031 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALTFELD, MARCUS · 2006 to 2015
$4.4M
Generation and Function of NK Cell MemoryR01AI111595 · NIAID · HARVARD MEDICAL SCHOOL · PI VON ANDRIAN, ULRICH H · 2013 to 2017
$4.1M
Antigen-Specific NK Cell Memory Against SIV and SIV VaccinesR56AI120828 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI REEVES, ROGER KEITH · 2015 to 2015
$717k
Enhancing Resolution of Memory NK cells in CMV- and SIV-infected macaquesR21AI118468 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI REEVES, ROGER KEITH · 2015 to 2016
$358k
T CELL RECOGNITION OF BACTERIAL SUPERANTIGENSF32AI009585 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI BROUSSARD, DANA R · 1996 to 1997
–
NIAID NIH HHS AI060354NIAID NIH HHS AI067031NIAID NIH HHS AI069259NIAID NIH HHS AI078526NIAID NIH HHS AI095985NIAID NIH HHS AI096040NIAID NIH HHS AI111595NIAID NIH HHS AI112521NIAID NIH HHS AI118468NIAID NIH HHS F32 AI009585NIAID NIH HHS P01 AI112521NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI067031NIAID NIH HHS R01 AI069259NIAID NIH HHS R01 AI111595NIAID NIH HHS R21 AI118468NIAID NIH HHS R56 AI120828NIAID NIH HHS U19 AI078526NIAID NIH HHS U19 AI095985NIAID NIH HHS U19 AI096040
6 · The paper itself

Abstract

Natural killer (NK) cells have traditionally been considered nonspecific components of innate immunity, but recent studies have shown features of antigen-specific memory in mouse NK cells. However, it has remained unclear whether this phenomenon also exists in primates. We found that splenic and hepatic NK cells from SHIV(SF162P3)-infected and SIV(mac251)-infected macaques specifically lysed Gag- and Env-pulsed dendritic cells in an NKG2-dependent fashion, in contrast to NK cells from uninfected macaques. Moreover, splenic and hepatic NK cells from Ad26-vaccinated macaques efficiently lysed antigen-matched but not antigen-mismatched targets 5 years after vaccination. These data demonstrate that robust, durable, antigen-specific NK cell memory can be induced in primates after both infection and vaccination, and this finding could be important for the development of vaccines against HIV-1 and other pathogens.

Indexed as

AIDS VaccinesAnimalsDendritic CellsHIV-1Immunologic MemoryKiller Cells, NaturalLiverMacaca mulattaReceptors, NK Cell Lectin-LikeSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusSpleenAIDS VaccinesReceptors, NK Cell Lectin-Like

Identifiers

PMID26193080
PMCPMC4545390
OpenAlexW1878895776

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.